원래 값
- **SFA**: NOVASMC 구조 기반 분석(2차). **Framework-Neutral**: SFA 미적용(1차). **Track원래 필드 27
- line_atom_id
S000ALINE-0fe36b49459ac700468d1f69
- manifest_id
SRC-d1a4fcb120faafe5
- page_atom_id
S000APAGE-e0c534def81be48179c4a4a0
- page_number
9
- line_number_on_page
12
- document_line_ordinal
316
- line_kind
LIST_ITEM_RENDERED
- heading_level
0
- heading_text
""
- heading_path_json
[{"level": 1, "lineId": "S000ALINE-de4fc4b6a461bb1c102cf470", "text": "아처로 2 (Archero 2 / 아처로2) — 1차 기본분석 (S000 BaseAnalysis / Framework-Neutral)"}, {"level": 2, "lineId": "S000ALINE-2af8dbc758c4800491b7f8cb", "text": "부록: 약어·용어"}]- parent_heading_line_id
S000ALINE-2af8dbc758c4800491b7f8cb
- basic_profile_context
0
- table_fragment_root_line_id
""
- raw_text
- **SFA**: NOVASMC 구조 기반 분석(2차). **Framework-Neutral**: SFA 미적용(1차). **Track
- raw_line_utf8_blob
{"encoding":"base64","data":"LSAqKlNGQSoqOiBOT1ZBU01DIOq1rOyhsCDquLDrsJgg67aE7ISdKDLssKgpLiAqKkZyYW1ld29yay1OZXV0cmFsKio6IFNGQSDrr7jsoIHsmqkoMeywqCkuICoqVHJhY2sK"}- start_char
620
- end_char_exclusive
697
- source_span_json
{"endCharExclusive":697,"extractorContract":"FULL_CORPUS_PDF_PAGE_TEXT_V1","kind":"pdf_extracted_page_text_char_range","page":9,"sourceSha256":"99b854051f49d2f523c9bcd3efc9e53ff0ba861f706dbcacfdd1f9c669d954f2","startChar":620}- content_hash
626b1f2ae45cff77ebd213d7c50c67a9f79f10257cac82a002666108d0e15afc
- source_generation
S000A_V3_LEGACY_CANONICAL_PDF
- consumer_eligibility
PRIVATE_RESEARCH_CONTEXT_ONLY
- comparison_eligibility
NOT_COMPARISON_GATE_OVERVIEW_ONLY
- semantic_public_eligibility
PRIVATE_ONLY_NOT_PUBLIC_AUTHORIZED
- authority_status
RESEARCH_LEGACY_CANONICAL_VERIFIED
- hold_id
""
- unresolved_json
[]
- facet_count
2